Medical Cannabis Studies

• View All (505)

Cannabinoids for treatment of chronic non-cancer pain: a systematic review of randomized trials (2011)

Cannabinoids are safe and more effective for the treatment of neuropathic pain with preliminary evidence of efficacy in fibromyalgia and rheumatoid arthritis without serious adverse effects. View study
Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial (2003)

This research was based on testing the idea that cannabinoids have a beneficial effect on spasticity and other symptoms related to multiple sclerosis. View study
Cannabinoids in experimental stroke: a systematic review and meta-analysis (2014)

This research will be based on the analysis of cannabinoids (CB) and their incidence in preclinical stroke. It was observed in this study that the CB significantly reduced the infarct volume and improved the functional outcome in the experimental stroke. View study
Cannabinoids in health and disease (2007)

This research was based on analyzing the dangers of abuse that led to the prohibition of the medicinal use of marijuana in most countries in the 1930s, as well as the recently found favorable indications of the medical use of cannabis sativa for the treatment of diseases.Cannabinoids in health and disease View study
Cannabinoids in models of chronic inflammatory conditions (No year)

In the present study we summarize the work on the effects of non-psychotropic cannabidiol (CBD) and a synthetic acid derived from cannabidiol (HU-320) in animal models of arthritis. The results suggest that the CBD and the HU-320 are promising as possible new anti-inflammatory agents. View study
Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications (2015)

This study states that cannabinoid-based drugs can serve as a new therapy capable of delaying / stopping neurodegeneration in acute and chronic neurodegenerative conditions. View study
Cannabinoids in the Treatment of Epilepsy (2015)

Studies in humans suggest that cannabidiol (CBD) and ?9-THC may have beneficial properties for the treatment of epilepsy. However, these studies are quite limited and therefore it is not possible to draw conclusions about them. If randomized clinical trials show that specific cannabinoids are safe and effective, those preparations should be approved and made available. View study
Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes (2006)

Cannabinoids have the property of causing the death of pancreatic tumor cells through a CB2 receptor. This and other findings in this study can help establish the basis for a new type of therapy for pancreatic cancer. View study
Cannabinoids Inhibit Glioma Cell Invasion by Down-regulating Matrix Metalloproteinase-2 Expression (2008)

In this research, the effect of cannabinoids on the expression of matrix metalloproteinase (MMP) and its effect on the invasion of tumor cells was evaluated. The local administration of # 9 -tetrahydrocannabinol (THC), the main active ingredient of cannabis, the expression of MMP-2 regulated downward in gliomas generated in mice, as determined by Western blot, immunofluorescence and quantitative PCR analysis in real time. View study
Cannabinoids inhibit neurodegeneration in models of multiple sclerosis (2003)

The therapeutic use of cannabis could alleviate symptoms and delay neurodegenerative processes in multiple sclerosis and other diseases. View study
Cannabinoids Inhibit the Vascular Endothelial Growth Factor Pathway in Gliomas (2004)

This research was based on the study on whether cannabinoids inhibit the vascular endothelial growth factor (VEGF) pathway in gliomas. The findings found provide a new pharmacological objective for cannabinoid-based therapies. View study
Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability (2011)

Cannabinoids can modulate intestinal permeability in an in vitro model of inflammation. This study suggests that cannabis-based drugs may be of therapeutic benefit in the treatment of inflammatory bowel disorders associated with abnormal intestinal permeability. View study